These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection]. Yu J; Li RY; Gao LJ; Lu QY; Wang XH Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):371-4. PubMed ID: 20367931 [TBL] [Abstract][Full Text] [Related]
46. Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia. Issa NC; Koo S; Lynch RC; Gay C; Hammond SP; Baden LR; Ghobrial IM; Finkelman MA; Marty FM J Clin Microbiol; 2012 Mar; 50(3):1054-6. PubMed ID: 22170932 [TBL] [Abstract][Full Text] [Related]
47. A multidisciplinary approach to managing invasive fungal disease. Preface. Ullmann AJ; Johnson A J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():i1. PubMed ID: 24319774 [No Abstract] [Full Text] [Related]
48. [Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders]. Liu F; Wu T; Cai P; Liu Y; Lu Y; Zhou JR; Yang F; Liu Q; Gao YQ; Luo RM; Zhang JP; Sun Y; Cao XY; Yin YM; Zhao YL; Wang JB; Tong CR; Lu DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1043-6. PubMed ID: 19698256 [TBL] [Abstract][Full Text] [Related]
49. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. Oz Y; Kiraz N Expert Rev Anti Infect Ther; 2011 Mar; 9(3):289-98. PubMed ID: 21417868 [TBL] [Abstract][Full Text] [Related]
50. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. Choi SH; Kang ES; Eo H; Yoo SY; Kim JH; Yoo KH; Sung KW; Koo HH; Kim YJ Pediatr Blood Cancer; 2013 Feb; 60(2):316-22. PubMed ID: 23042761 [TBL] [Abstract][Full Text] [Related]
51. Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit. Hung CY; Kao KC; Wang PN; Hu HC; Hsieh MJ; Fu JY; Chang CH; Li LF; Huang CC; Tsai YH; Yang CT BMC Infect Dis; 2012 Feb; 12():44. PubMed ID: 22339791 [TBL] [Abstract][Full Text] [Related]
52. Invasive fungal infections in pediatric hematopoietic stem cell transplant patients. Simms-Waldrip T; Rosen G; Nielsen-Saines K; Ikeda A; Brown B; Moore T Infect Dis (Lond); 2015 Apr; 47(4):218-24. PubMed ID: 25650728 [TBL] [Abstract][Full Text] [Related]
53. [Invasive fungous infections in post haematopoietic stem cell transplant patients--editorial]. Cetkovský P Vnitr Lek; 2007 Sep; 53(9):931-3. PubMed ID: 18019659 [No Abstract] [Full Text] [Related]
54. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Jantunen E; Salonen J; Juvonen E; Koivunen E; Siitonen T; Lehtinen T; Kuittinen O; Leppä S; Anttila VJ; Itälä M; Wiklund T; Remes K; Nousiainen T Eur J Haematol; 2004 Sep; 73(3):174-8. PubMed ID: 15287914 [TBL] [Abstract][Full Text] [Related]
56. β-D-glucan testing is important for diagnosis of invasive fungal infections. Theel ES; Doern CD J Clin Microbiol; 2013 Nov; 51(11):3478-83. PubMed ID: 23850953 [TBL] [Abstract][Full Text] [Related]
57. [Current status and future perspectives of invasive fungal infections after hematopoietic stem cell transplantation]. Li Y; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):517-22. PubMed ID: 21518521 [TBL] [Abstract][Full Text] [Related]
58. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404 [TBL] [Abstract][Full Text] [Related]